Motus GI Holdings, Inc. (MOTS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Nov 6, 2025, 4:00 PM EST
Motus GI Holdings Employees
Motus GI Holdings had 15 employees as of December 31, 2023. The number of employees decreased by 34 or -69.39% compared to the previous year.
Employees
15
Change (1Y)
-34
Growth (1Y)
-69.39%
Revenue / Employee
$21,800
Profits / Employee
-$1,073,467
Market Cap
719.00
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 15 | -34 | -69.39% |
| Dec 31, 2022 | 49 | 19 | 63.33% |
| Dec 31, 2021 | 30 | 6 | 25.00% |
| Dec 31, 2020 | 24 | -25 | -51.02% |
| Dec 31, 2019 | 49 | 5 | 11.36% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
Motus GI Holdings News
- 1 year ago - Introducing Motus Protect: Unique Risk Management Solutions for Companies Dependent on Employee-Owned Vehicles - Business Wire
- 1 year ago - Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer - Business Wire
- 1 year ago - Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds - GlobeNewsWire
- 1 year ago - Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract - GlobeNewsWire
- 1 year ago - Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders - GlobeNewsWire
- 1 year ago - Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation - GlobeNewsWire
- 2 years ago - Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January - Corcept Therapeutics (NASDAQ:CORT), Kintara Therapeutics (NASDAQ:KTRA) - Benzinga